Literature DB >> 29137821

Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine.

José Esparza1, Livia Schrick2, Clarissa R Damaso3, Andreas Nitsche2.   

Abstract

For almost 150 years after Edward Jenner had published the "Inquiry" in 1798, it was generally assumed that the cowpox virus was the vaccine against smallpox. It was not until 1939 when it was shown that vaccinia, the smallpox vaccine virus, was serologically related but different from the cowpox virus. In the absence of a known natural host, vaccinia has been considered to be a laboratory virus that may have originated from mutational or recombinational events involving cowpox virus, variola viruses or some unknown ancestral Orthopoxvirus. A favorite candidate for a vaccinia ancestor has been the horsepox virus. Edward Jenner himself suspected that cowpox derived from horsepox and he also believed that "matter" obtained from either disease could be used as preventative of smallpox. During the 19th century, inoculation with cowpox (vaccination) was used in Europe alongside with inoculation with horsepox (equination) to prevent smallpox. Vaccine-manufacturing practices during the 19th century may have resulted in the use of virus mixtures, leading to different genetic modifications that resulted in present-day vaccinia strains. Horsepox, a disease previously reported only in Europe, has been disappearing on that continent since the beginning of the 20th century and now seems to have become extinct, although the virus perhaps remains circulating in an unknown reservoir. Genomic sequencing of a horsepox virus isolated in Mongolia in 1976 indicated that, while closely related to vaccinia, this horsepox virus contained additional, potentially ancestral sequences absent in vaccinia. Recent genetic analyses of extant vaccinia viruses have revealed that some strains contain ancestral horsepox virus genes or are phylogenetically related to horsepox virus. We have recently reported that a commercially produced smallpox vaccine, manufactured in the United States in 1902, is genetically highly similar to horsepox virus, providing a missing link in this 200-year-old mystery.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Cowpox; History; Horsepox; Jenner; Smallpox; Vaccination; Vaccinia; Variola

Mesh:

Substances:

Year:  2017        PMID: 29137821     DOI: 10.1016/j.vaccine.2017.11.003

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

Review 1.  Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.

Authors:  Jonas D Albarnaz; Alice A Torres; Geoffrey L Smith
Journal:  Viruses       Date:  2018-02-28       Impact factor: 5.048

2.  Serological Evidence of Orthopoxvirus Circulation Among Equids, Southeast Brazil.

Authors:  Iara A Borges; Mary G Reynolds; Andrea M McCollum; Poliana O Figueiredo; Lara L D Ambrosio; Flavia N Vieira; Galileu B Costa; Ana C D Matos; Valeria M de Andrade Almeida; Paulo C P Ferreira; Zélia I P Lobato; Jenner K P Dos Reis; Erna G Kroon; Giliane S Trindade
Journal:  Front Microbiol       Date:  2018-03-08       Impact factor: 5.640

Review 3.  Rapid Viral Diagnosis of Orthopoxviruses by Electron Microscopy: Optional or a Must?

Authors:  Hans R Gelderblom; Dick Madeley
Journal:  Viruses       Date:  2018-03-22       Impact factor: 5.048

4.  The origins and genomic diversity of American Civil War Era smallpox vaccine strains.

Authors:  Ana T Duggan; Jennifer Klunk; Ashleigh F Porter; Anna N Dhody; Robert Hicks; Geoffrey L Smith; Margaret Humphreys; Andrea M McCollum; Whitni B Davidson; Kimberly Wilkins; Yu Li; Amanda Burke; Hanna Polasky; Lowell Flanders; Debi Poinar; Amogelang R Raphenya; Tammy T Y Lau; Brian Alcock; Andrew G McArthur; G Brian Golding; Edward C Holmes; Hendrik N Poinar
Journal:  Genome Biol       Date:  2020-07-20       Impact factor: 13.583

5.  Genes that Control Vaccinia Virus Immunogenicity.

Authors:  S N Shchelkunov; G A Shchelkunova
Journal:  Acta Naturae       Date:  2020 Jan-Mar       Impact factor: 1.845

Review 6.  Challenges and Achievements in Prevention and Treatment of Smallpox.

Authors:  Sharon Melamed; Tomer Israely; Nir Paran
Journal:  Vaccines (Basel)       Date:  2018-01-29

7.  With regard to the bicentennial of the independence of Colombia: Reading practices of Antonio Nariño and the development of a presumably effective vaccine against smallpox

Authors:  Sandra-Milena Moreno; Freddy Moreno-Gómez
Journal:  Biomedica       Date:  2020-05-01       Impact factor: 0.935

8.  Synthetic horsepox viruses and the continuing debate about dual use research.

Authors:  Ryan S Noyce; David H Evans
Journal:  PLoS Pathog       Date:  2018-10-04       Impact factor: 6.823

9.  Beyond the myths: Novel findings for old paradigms in the history of the smallpox vaccine.

Authors:  José Esparza; Andreas Nitsche; Clarissa R Damaso
Journal:  PLoS Pathog       Date:  2018-07-26       Impact factor: 6.823

10.  CSV2018: The 2nd Symposium of the Canadian Society for Virology.

Authors:  Nathalie Grandvaux; Craig McCormick
Journal:  Viruses       Date:  2019-01-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.